|
|
|
|
|
|
| Thomson Reuters MetaCore suite instrumental in helping researchers find disease's cure |
Philadelphia, PA, London, UK, Dec 2, 2011 - (ACN Newswire) - Thomson Reuters, the world's leading source of intelligent information for businesses and professionals and the global leader in scientific information, announced today a grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to create and publish the world's most comprehensive source of biological maps for Parkinson's disease (PD).
The project aims to identify possible causes of Parkinson's disease by mapping biological mutations of the Leucine-rich repeat kinase 2 (LRRK2) protein, the most common genetic contributor to the disease discovered to date. The maps trace the disease's biological pathways to pinpoint relevant biomarkers, which are biological molecules that signal an abnormal process or disease. They also support the drug discovery process for treating PD.
"Researching the LRRK2 protein is a top priority for our foundation," said Brian Fiske, Ph.D., director of research programs at MJFF. "We are committed to providing valuable tools, such as those from Thomson Reuters, for the research community to visually depict LRRK2 research data in useful and comprehensible formats."
Thomson Reuters creates biological maps using the highest quality scientific literature data that is manually annotated using the business's proprietary curation methods. The data selected for the maps is evaluated based on select criteria to ensure exceptional depth, breadth and quality of information for the researchers using it.
"The pathway maps and unique content Thomson Reuters is developing for the MJFF project are especially valuable in shedding light on Parkinson's disease and its cause," said Jon Brett-Harris, executive vice president, Life Sciences, Thomson Reuters. "The maps will provide PD researchers with a resource to reveal the mechanisms behind the disease and further extend the drug discovery process. We are honoured to have the opportunity to work with the MJFF on this critical program."
Users of the Thomson Reuters MetaCore offering, an integrated software suite delivering high-quality biological systems, will be able to access the pathway maps for greater insight via MetaCore's analysis tools.
For more information about pathway analysis tools at Thomson Reuters, please visit http://thomsonreuters.com/products_services/science/science_products/a-z/metacore/ .
About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $270 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. Now through December 31, 2012, all new and increased giving to The Michael J. Fox Foundation, as well as gifts from donors who have not given since 2009 or earlier, will be matched on a dollar-for-dollar basis with the $50-million Brin Wojcicki Challenge, launched by Sergey Brin and Anne Wojcicki. For more information, visit: www.michaeljfox.org.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
CONTACT
Alyssa Velekei
Thomson Reuters
+1 215 823 1894
alyssa.velekei@thomsonreuters.com
Laura Gaze
Thomson Reuters
+1 203 868 3340
laura.gaze@thomsonreuters.com
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
Copyright (c) Thomson Reuters 2011. All rights reserved.
Topic: Press release summary
Source: Thomson Reuters
Sectors: Daily Finance
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
